Meprobamate
NDC 69097-974, Meprobamate, tablet, from Cipla USA Inc..
- Product NDC
- 69097-974
- Status
- Listed
- Labeler
- Cipla USA Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040797
- DEA schedule
- CIV
curl https://api.healthcare.dev/v1/drugs/ndc/69097-974 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MEPROBAMATE200 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-974-07 | 69097097407 | 100 TABLET in 1 BOTTLE (69097-974-07) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/17d814e2-b277-4dce-8615-e7fd7cab773fNADAC price for package 69097097407
GET /v1/drugs/nadac/69097097407
Use it
Look up 69097-974 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-974 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-974. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.